NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its price objective boosted by investment analysts at Canaccord Genuity from C$11.00 to C$12.00 in a research report issued on Monday. The firm presently has a “hold” rating on the stock. Canaccord Genuity’s target price would suggest a potential upside of 4.90% from the company’s current price.

A number of other research analysts also recently commented on the company. Scotiabank increased their price objective on NorthWest Health Prop Real Est Inv Trust from C$11.25 to C$11.50 and gave the company a “sector perform” rating in a report on Monday, October 16th. BMO Capital Markets reiterated a “market perform” rating and issued a C$12.00 price objective on shares of NorthWest Health Prop Real Est Inv Trust in a report on Wednesday, October 18th. National Bank Financial reiterated a “sector perform” rating and issued a C$11.75 price objective on shares of NorthWest Health Prop Real Est Inv Trust in a report on Monday, October 16th. Finally, Royal Bank Of Canada upped their target price on NorthWest Health Prop Real Est Inv Trust from C$11.00 to C$11.50 and gave the company a “sector perform” rating in a research report on Monday, October 16th. Five research analysts have rated the stock with a hold rating, NorthWest Health Prop Real Est Inv Trust presently has an average rating of “Hold” and a consensus price target of C$11.63.

NorthWest Health Prop Real Est Inv Trust (NWH.UN) traded down C$0.01 on Monday, hitting C$11.44. The stock had a trading volume of 125,366 shares, compared to its average volume of 285,938. NorthWest Health Prop Real Est Inv Trust has a fifty-two week low of C$9.60 and a fifty-two week high of C$11.50.

ILLEGAL ACTIVITY WARNING: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/13/northwest-health-prop-real-est-inv-trusts-nwh-un-hold-rating-reaffirmed-at-canaccord-genuity.html.

NorthWest Health Prop Real Est Inv Trust Company Profile

NorthWest Healthcare Properties Real Estate Investment Trust is an open‐ended real estate investment trust (REIT). The Company’s objectives are to manage its investments to provide stable, sustainable and growing cash flows through investments in healthcare real estate across the globe; build a diversified, growth‐oriented global portfolio of healthcare properties based on an initial portfolio of investments in Australasia, Brazil, Germany and Canada; capitalize on internal growth and seek accretive healthcare real estate acquisition opportunities in its target international markets, with a focus on Australasia, Brazil, Germany and Canada; grow the value of its assets and maximize the long‐term value of its Trust Units through its management, and provide predictable and growing cash distributions per unit, on a tax‐efficient basis.

Analyst Recommendations for NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN)

Receive News & Stock Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related stocks with our FREE daily email newsletter.